The DOI matches its Crossref record.
Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study
Abstract
We conducted a controlled, blinded, multicenter study of disulfiram treatment of alcoholism in 605 men randomly assigned to 250 mg of disulfiram (202 men); 1 mg of disulfiram (204 men), a control for the threat of the disulfiram-ethanol reaction; or no disulfiram (199 men), a control for the counseling that all received. Bimonthly treatment assessments were done for one year. Relative/ friend interviews and blood and urine ethanol analyses were used to corroborate patients' reports. There were no significant differences among the groups in total abstinence, time to first drink, employment, or social stability. Among the patients who drank and had a complete set of assessment interviews, those in the 250-mg disulfiram group reported significantly fewer drinking days (49.0 ±8.4) than those in the 1-mg (75.4±11.9) or the no-disulfiram (86.5 ± 13.6) groups. There was a significant relationship between adherence to drug regimen and complete abstinence in all groups. We conclude that disulfiram may help reduce drinking frequency after relapse, but does not enhance counseling in aiding alcoholic patients to sustain continuous abstinence or delay the resumption of drinking. (JAMA1986;256:1449-1455)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Compliance has been a serious impediment in disulfiram research in numerous studies [26], [27].”
From Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis (2014) · cites this paper as [27]
Citations
Cited by
Sorted by citations
Items 301–400 of 421
Active placebos in antidepressant trials
Moncrieff, J., & Wessely, S. C. (1998) · The British Journal of Psychiatry · doi:10.1192/bjp.173.1.88b · Cited by 5
Use of the Internet for Addiction Education
Galanter, M. S., Keller, D. S., Dermatis, H., et al. (1998) · American Journal on Addictions · doi:10.1111/j.1521-0391.1998.tb00462.x · Cited by 5
Stewart, S. F., & Day, C. P. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50034-6 · Cited by 5
Pharmacotherapy of Alcoholism ‐10 Years of Progress
Anton, R. F., & Mann, K. F. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01770.x · Cited by 4
Mandaji, J. V. G., Pedro, M. O. P., Leopoldo, K., Alemar, J. P., Torales, J. C., Ventriglio, A., & Castaldelli-Maia, J. M. (2025) · Brain Sciences · doi:10.3390/brainsci15060542 · Cited by 5
Cadagan, C., Russell‐Guzmán, J., Américo-Da-Silva, L., Montaña, P., Barrientos, G. C., Buvinic, S., Tapia, G., Estrada, M., & Llanos, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-30058-6 · Cited by 4
“DSF, originally approved for the treatment of chronic alcohol dependence, exhibits a well-established safety profile in adherent patients, and long-term administration has not been associated with the development of pharmacological tolerance 15 .”
Liver Transplantation in Alcohol-Associated Liver Disease
Rady, E. D., Anouti, A., Thimphitthaya, C., & Cotter, T. G. (2025) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.12.001 · Cited by 4
Petrášek, J., & Szabó, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_15 · Cited by 4
Disulfiram: Side Effects and Toxicity
Sousa, A. D. (2019) · Springer eBooks · doi:10.1007/978-981-32-9876-7_7 · Cited by 4
Pharmacological interventions for alcohol misuse in correctional settings: A systematic review
Slavin‐Stewart, C., Minhas, M., Turna, J., Brasch, J. S., Olagunju, A. T., Chaimowitz, G. A., & MacKillop, J. M. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14751 · Cited by 4
Chick, J. (1987) · British Journal of Addiction · doi:10.1111/j.1360-0443.1987.tb01472.x · Cited by 4
Why is disulfiram not on the PBS?
Lipworth, W. L., WODAK, A. D., Haber, P., & Day, R. O. (2011) · The Medical Journal of Australia · doi:10.5694/mja11.10708 · Cited by 4
Generalizing From Controlled Treatment Outcome Studies
Gottheil, E., Sterling, R. C., & Weinstein, S. P. (1995) · American Journal on Addictions · doi:10.1111/j.1521-0391.1995.tb00272.x · Cited by 4
Strategies for the Treatment of Alcoholism
Allen, J. P., & Mattson, M. E. (1993) · Springer eBooks · doi:10.1007/978-1-4615-2914-9_16 · Cited by 4
Comorbid substance use among persons with HIV and chronic pain
Lum, P. J., & Bruce, R. D. (2016) · Wiley eBooks · doi:10.1002/9781118777374.ch9 · Cited by 4
Chapter 55. Treatment of Alcohol Use Disorder
Mason, B. J., Ritvo, E. C., & Bonci, A. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as55 · Cited by 3
Zyl, P. M. V. (2016) · African Journal of Primary Health Care & Family Medicine · doi:10.4102/phcfm.v8i1.1053 · Cited by 3
Potretzke, S., Robins, M. T., & Ryabinin, A. E. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104676 · Cited by 4
“, 2014), their use is often unsuccessful clinically (Fuller et al., 1986; Oslin et al., 2003; Haney and Spealman, 2008; Mann et al., 2013; Jonas et al., 2014).”
BackgroundRosenstand, N. J., Nielsen, A. S., Skøt, L., Anhøj, S. J., Nielsen, D. G., Højlund, M., & Mellentin, A. I. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221229160300 · Cited by 3
“Table 1 summarizes the available pharmacological treatments for AUD [18-24].”
BackgroundCurrent treatments of alcohol use disorder
Dionisi, T., Sario, G. D., Mori, L. D., Spagnolo, G., Antonelli, M., Tarli, C., Sestito, L., Mancarella, F. A., Ferrarese, D., Mirijello, A., et al. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.02.005 · Cited by 4
Managing Pain in Patients With Comorbid Alcohol Use Disorder and Chronic Pain
Maleki, N., Thompson, B., Janiuk, K., Dhingra, L. K., & Chen, L. L. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00563-1 · Cited by 3
Uso potencial dos anticonvulsivantes no tratamento ambulatorial da dependência de álcool
Castro, L. A., & Couzi, C. (2006) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852006000300007 · Cited by 3
Pharmacotherapy of alcohol and drug problems
Sellers, E. M., & Romach, M. K. (1991) · Drug and Alcohol Review · doi:10.1080/09595239100185251 · Cited by 3
Tratamiento farmacológico de la dependencia alcohólica
Ponce, G., Jiménez‐Arriero, M. Á., & Rubio, G. (2003) · Trastornos Adictivos · doi:10.1016/s1575-0973(03)70103-2 · Cited by 3
Cantilena, L. R., Katki, A. G., Klecker, R. W., & Collins, J. M. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004270224 · Cited by 3
Use of Court‐ordered Supervised Disulfiram Therapy at DVA Medical Centers in the United States
Martin, B., Mangum, L., & Beresford, T. P. (2005) · American Journal on Addictions · doi:10.1080/10550490590949541 · Cited by 3
Espiridion, E. D. (2019) · Cureus · doi:10.7759/cureus.6287 · Cited by 4
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50016-7 · Cited by 3
Garbutt, J. C. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_14 · Cited by 4
The evidence for drug treatment of alcohol dependence in liver transplant patients
Beresford, T. P., & Martin, B. (2007) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32803fb77d · Cited by 3
Disulfiram in the treatment of drinking problems: a response to commentaries
Fuller, R. K., & Gordis, E. (2003) · Addiction · doi:10.1111/j.1360-0443.2004.00639.x · Cited by 3
Self-citationColchicine in the Treatment of Cirrhosis
(1988) · New England Journal of Medicine · doi:10.1056/nejm198811103191912 · Cited by 3
Acute and Chronic Alcohol-Related Disorders
Thier, P. (2003) · Elsevier eBooks · doi:10.1016/b978-012125831-3/50266-5 · Cited by 3
Alharbi, F., & el‐Guebaly, N. (2012) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e318246f4af · Cited by 2
“’’ Only 20% were DSFadherent, and they reported fewer drinking days.(7) Adherence became a critical methodological issue in determining the effectiveness of DSF.”
BackgroundDisulfiram in the Management of Alcohol Dependence
Sousa, A. D. (2019) · Springer eBooks · doi:10.1007/978-981-32-9876-7_3 · Cited by 2
Patil, S. K. G., Mattikoppa, N. V., & Gowda, M. R. (2024) · Indian Journal of Psychological Medicine · doi:10.1177/02537176241260468 · Cited by 2
Bai, Y., Chen, P., Wu, W., Yang, Q. K., Qu, T., Shuai, W., Du, Y., & Jiang, S. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107569 · Cited by 2
Pharmacotherapy of Alcohol and Drug Dependence
Swift, R. M., & Aoun, E. G. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0029-7 · Cited by 2
“A large, multicenter double-blind, randomized controlled trial (RCT) conducted in 605 alcohol-dependent veterans found disulfiram to be no more effective than placebo in promoting alcohol abstinence [21].”
BackgroundResearch Advances in Pharmacotherapy for Alcoholism
Litten, R. Z., & Allen, J. P. (1992) · Humana Press eBooks · doi:10.1007/978-1-4612-0363-6_3 · Cited by 2
Treatment of psychiatric aspects of alcohol misuse
Naik, P. C., & Brownell, L. W. (1999) · Hospital Medicine · doi:10.12968/hosp.1999.60.3.1061 · Cited by 2
Tratamientos combinados en la adicción a drogas
Hervás, E. S. (2006) · Trastornos Adictivos · doi:10.1016/s1575-0973(06)75105-4 · Cited by 2
Naranjo, C. A., & Bremner, K. E. (1996) · Substance Abuse · doi:10.1080/08897079609444727 · Cited by 2
Alcoholic Subjects With Anxiety Disorder
Moak, D. H., Anton, R. F., Malcolm, R. J., Randall, C. L., & Brady, K. T. (1993) · American Journal on Addictions · doi:10.1111/j.1521-0391.1993.tb00369.x · Cited by 2
Kaminer, Y. (2001) · Elsevier eBooks · doi:10.1016/b978-008043577-0/50033-x · Cited by 2
Interventionsstudien zur Rückfallprophylaxe: Ergebnisse und Probleme
Lauer, G. (1988) · Springer eBooks · doi:10.1007/978-3-642-77375-4_5 · Cited by 2
GLP-1 Receptor Agonists vs Alternatives for Alcohol Use Disorder: A Multi-Target Trial EmulationPreprint
Rodriguez, P. J., Lusk, J. B., Mehta, H. B., Levy, J. F., Kalogeropoulos, A. P., Soneji, S. S., Webber, E., Gluckman, T. J., & Stucky, N. L. (2025) · medRxiv · doi:10.1101/2025.06.07.25329184 · Cited by 2
Clinical Application of Findings from Animal Research on Alcohol Self-Administration and Dependence
Romach, M. K., & Tomkins, D. M. (1995) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78435-4_11 · Cited by 2
Disulfiram Should Remain Second-line Treatment for Most Patients with Alcohol Use Disorder.
Axelrath, S. (2024) · Journal of addiction medicine · doi:10.1097/adm.0000000000001360
Sherin, K. M., & Seikel, S. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1160-8.10049-1 · Cited by 1
Stewart, S. F., & Day, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00028-0 · Cited by 3
Sallam, H. S., Li, H., & Chen, J. D. Z. (2021) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13377 · Cited by 1
Mutschler, J., Müller, C. A., & Soyka, M. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23021-9.00007-2 · Cited by 1
Treatments for Substance Use Disorders
da Costa, S. C., Moustafa, Y., Vasquez, A., & Rummans, T. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00047-6 · Cited by 1
Streem, D. W. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6643-9.00157-0 · Cited by 1
Milhorn, H. T. (2017) · Springer eBooks · doi:10.1007/978-3-319-63040-3_16 · Cited by 1
Addictive Disorders in Psychiatric Medicine
Yuodelis‐Flores, C., Bennett, W. M., Meredith, C. W., & Ries, R. K. (2010) · Wiley eBooks · doi:10.1002/9780470710449.ch13 · Cited by 1
Research strategies to assess pharmacotherapies for alcoholism
Naranjo, C. A., Bremner, K. E., & Poulos, C. X. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(96)00033-4 · Cited by 1
Reply to Comments by Mr Martin and Dr Beresford
Suh, J. J., Gallis, T. L., Kampman, K. M., & Pettinati, H. M. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000280313.96613.72 · Cited by 1
The continuing search for the “elixir of temperance”
Drummond, C., & Moncrieff, J. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02974.x · Cited by 1
Promising Themes in Alcoholism Treatment Research
Allen, J. P., Lowman, C., Mattson, M. E., & Litten, R. Z. (1992) · Humana Press eBooks · doi:10.1007/978-1-4612-0363-6_2 · Cited by 2
An Overview of Substance Use Disorders and Their Management
Saunders, J. B., Sitharthan, T., & Krabman, P. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_132 · Cited by 1
OUTPATIENT MANAGEMENT OF ALCOHOL ABUSE
Vinson, D. C., & Cooley, F. B. (1993) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)00365-1 · Cited by 1
Johnson, B. A., & Ait‐Daoud, N. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_47 · Cited by 1
Psychosocial interventions for alcohol use disorders
de Lima, M. S., Soares, B. G., & Farrell, M. (2001) · doi:10.1002/14651858.cd003027 · Cited by 1
Cook, B. L., Garvey, M. J., & Shukla, S. (1987) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(21)01038-1 · Cited by 1
Psychosocial interventions for alcohol use disorders
de Lima, M. S., Soares, B. G., & Farrell, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003027.pub2 · Cited by 1
Choi, D., Karpyak, V. M., Frye, M. A., Hall‐Flavin, D. K., & Mrazek, D. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50059-7 · Cited by 1
(2000) · Time to knit · doi:10.1016/s0246-1072(19)30170-1 · Cited by 1
Outlook: Prospects for alcoholism treatment
Gordis, E. (1994) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7330-7_39
“Excellent multi-site studies of disulfiram (Fuller et al., 1986) and lithium (Dorus et aI.”
BackgroundTraitements chimiothérapiques de l’alcoolodépendance et des conduites addictives
Millet, B., Vanelle, J., & Benyaya, J. (2014) · Elsevier eBooks · doi:10.1016/b978-2-294-74176-0.00011-8
Network Therapy in Addiction Treatment
Galanter, M. S. (2014) · Springer eBooks · doi:10.1007/978-88-470-5322-9_45
Edwards, G., Marshall, E. J., & Cook, C. C. H. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543722.021
Brust, J. C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-2-84299-712-0.50012-7
Effect of immunization against alcohol dehydrogenase on the behavior of white rats
Fedorova, I. M., Danilova, R. A., & Ашмарин, И. П. (1994) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf02446457
Pharmacological treatment of alcoholism
Monteiro, M. G. (1992) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1992.tb02817.x
Pharmacotherapeutic Interventions to Maintaining Abstinence in Alcoholism
Namkoong, K. (2006) · Journal of the Korean Medical Association · doi:10.5124/jkma.2006.49.2.134
Reply (to letter by C. Brewer)
SCHILLING, R. F., & El‐Bassel, N. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00946.x
Aslan, A. A., Yalçın, Ö., Arıkan, Z., Kuruoğlu, A., Çoşar, B., & Konuk, N. (2013) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120903122839
Current Trends in the Pharmacological Treatment of Alcohol‐related Problems
Naranjo, C. A. (1988) · Australian Drug and Alcohol Review · doi:10.1080/09595238880000211
Entzug geschafft — was kommt jetzt?
Müller, C. A., & Heinz, A. (2013) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-013-0644-3
Disulfiram for Alcohol and Other Drug Use
Kerfoot, K. E., & Petrakis, I. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398338-1.00038-5 · Cited by 1
Specialist treatment of drinking problems
Humphreys, K. N., & Lingford-Hughes, A. R. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316258057.014
Jarlais, D. C. D., & Hubbard, R. L. (2009) · doi:10.1093/med/9780199218707.003.0076
Pharmacological Treatments for Alcohol–Cocaine Interactions
Bühler, K., & López‐Moreno, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803750-8.00059-2
Pharmacotherapies for the Treatment of Alcohol Dependence
Wright, T. M., Baros, A. M., & Anton, R. F. (2007) · Elsevier eBooks · doi:10.1016/b978-008044927-2/50056-0
State-of-the-Art Treatment of Alcohol Use Disorder
Ray, L. A., Hartwell, E. E., Green, R., & Venegas, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54856-4.00008-0
Genetic Markers Related to Alcohol Use and Abuse
Bornhorst, J. A., & McMillin, G. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815607-0.00004-6
Farmakoterapia wspomagająca w leczeniu uzależnienia od alkoholu i narkotyków
Swift, R. M., & Leggio, L. (2013) · Wydawnictwa Uniwersytetu Warszawskiego eBooks · doi:10.31338/uw.9788323513759.pp.287-312
Traitements chimiothérapiques de l’alcoolodépendance et des conduites addictives
Millet, B., Vanelle, J., & Benyaya, J. (2010) · Elsevier eBooks · doi:10.1016/b978-2-294-01922-7.00011-3
New Options for the Treatment of Alcohol Dependence
Volpicelli, J. R. (2005) · Psychiatric Annals · doi:10.3928/00485713-20050601-05
Opioid Analegiscs and Drugs for Alcohol Use Disorder
Sadek, J. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-60766-1_9
Chapter 9. Treatment of Alcohol-Related Disorders
Braxton, A., Wright, T., & Myrick, H. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb09
Treatment: Context and content
Humphreys, K. N., & Lingford-Hughes, A. R. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316258057.009
Quand la science véhicule de l’illusion. L’affaire « Chlorpropamide alcohol flushing » (1978–1987)
Vialettes, B. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.04.007
Galanter, M. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_32
Galanter, M. S. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb28
Schuckit, M. A. (1995) · Springer eBooks · doi:10.1007/978-1-4757-2407-3_15
Anjum, A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_14
Schuckit, M. A. (2000) · Springer eBooks · doi:10.1007/978-1-4757-3232-0_15
Soyka, M. (1999) · Springer eBooks · doi:10.1007/978-3-642-58462-6_12
Metadata
- Authors
- Fuller, R. K.
- Corresponding author
- Fuller, Richard K.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1986-09-19
- Volume
- 256
- Issue
- 11
- Pages
- 1449
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3027683458
- Cited by
- 431
- References
- 0
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 13 · 2023: 10 · 2022: 10 · 2021: 14 · 2020: 11 · 2019: 11 · 2018: 6 · 2017: 12 · 2016: 15 · 2015: 7 · 2014: 17 · 2013: 17 · 2012: 8
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Keywords
- disulfiram, alcoholism, alcoholism treatment, disulfiram-ethanol reaction, abstinence, drinking frequency, relapse, medication adherence, counseling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review